Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Chinese Journal of Internal Medicine ; (12): 637-643, 2021.
Artigo em Chinês | WPRIM | ID: wpr-911426

RESUMO

Objective:Cholangiocarcinoma (CCA) is a malignant tumor derived from bile duct epithelial cells with extremely poor prognosis. The Hippo-Yes-associated protein (YAP)/transcription activator with PDZ binding motif (TAZ) signaling plays a critical role in cancer stem cell biology. Previous studies have shown that the positive expression of YAP/TAZ in CCA predicts larger tumor size and unfavorable clinical outcomes. We aim to evaluate the prognostic value of YAP/TAZ detection in CCA patients.Methods:CCA patients who underwent radical resection were retrospectively analyzed at our institution from January 2011 to June 2016. Postoperative pathological specimens were scored by YAP/TAZ immunohistochemical staining. The prognostic value of YAP/TAZ was analyzed by multivariate Cox-proportional hazards model.Results:A total of 91 CCA patients were enrolled. During a median follow-up time of 11.0 months, 69.2% patients relapsed and 45.1% died. The median OS and DFS were 10.7 months and 8.8 months respectively. The YAP/TAZ dual positive patients owned a worse TNM stage ( P=0.015), poorer tissue differentiation ( P=0.007), and a higher CA199 than those in negative patients. Multivariate Cox analysis identified that YAP/TAZ dual positivity as a significant factor predicted poorer OS ( P=0.010) and DFS ( P=0.028) in CCA patients after radical resection. In subgroup analysis, YAP/TAZ combination also significantly predicted OS ( P=0.044) and DFS ( P=0.043) in CCA patients with positive lymphatic metastasis and/or surgical margin who required adjuvant therapy. Conclusions:YAP/TAZ positivity is an independent predictive factor for survival in CCA patients after radical resectiony.

2.
Chinese Journal of General Surgery ; (12): 877-880, 2008.
Artigo em Chinês | WPRIM | ID: wpr-397731

RESUMO

Objective To evaluate CT guided 125I seeds implantation for liver metastasis of colorectal cancer. Methods The retrospective analysis was undertaken in 15 colorectal cancer patients with 33 foci of hepatic metastases from Jul 2006 to Aug 2007, receiving CT guided 125I radioactive seeds implantation according to TPS or Halarism's experience function: mCi = Da × 5, Results All the patients were followed-up by CT scan after 3 months. There were 2 of complete remission (CR) , 10 of partial remission (PR), 3 of stable disease (SD). All patients are still alive now, the lougest follow-up time is 20 months, and the shortest is 6 months, the average followed span is 12 months. Conclusion CT guided 125I seeds implantation is a safe and effective method in the treatment of liver metastasis caused by colorectal cancer.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA